<?xml version="1.0" encoding="UTF-8"?>
<records xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://www.doaj.org/schemas/doajArticles.xsd">


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>1</startPage>
              <endPage>6</endPage>
              <doi>10.26663/cts.2026.001</doi>
              <publisherRecordId>282</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">The impact of ebus-tbna, f-18 fdg pet suv-max value, and tomographic measurement of lymph node density in the diagnosis of mediastinal malignant lymph nodes</title>
                <authors>
                              <author>
                                <name>Necati  Solak</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet  Cetin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet  Buyukevli</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Busra Ozdemir Ciftlik</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Koray  Aydogdu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Serdar  Han</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tevfik  Kaplan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Health Sciences University, Ankara Etlik City Hospital, Thoracic Surgery Clinic, Ankara, Türkiye</affiliationName><affiliationName affiliationId="2">Kirikkale University School of Medicine, Department of Thoracic Surgery Ankara, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is
a minimally invasive effective, simple procedure and has replaced mediastinoscopy in diagnosis of
mediastinal lymphadenopathies. But still there is an effort to increase diagnostic value of EBUS-TBNA
and to meet additional information to guide biopsy especially in false negative situations.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; In this retrospective study between December 2022 and December 2023, 90
patients, 176 lymph nodes were sampled with EBUS-TBNA. Patients&#039; characteristics, lymph node density
on CT, PET-CT findings, pathological diagnosis by EBUS-TBNA, and surgery were all written down.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Sensitivity, specificity, negative predictive value, and positive predictive value of EBUS-TBNA were
78.8%, 95.8%, 85%, and 90.3%, respectively. Mean SUV-max values in PET tomography were 2.66±0.56
in benign lymph nodes, whereas it was 9.26±2.34 in malignant lymph nodes and this was significantly
higher than benign lymph nodes (p&lt;0,001). For detecting malignancy, cut-off value of SUV-max was found
6.02±1.84 and sensitivity and specificity were 55.3%, 95.8% respectively (AUC= 0,895 95% CI (0,844-
0,946), p&lt;0.001). Mean tomographic lymph node density was 25.05±4.67 HU in benign lymph nodes. Also
mean tomographic lymph node density was 31.55±5.34 HU and significantly higher than benign lymph
nodes (p=0.03). Cut-off value of density for detecting malignancy was found 29,05±4.78 and sensitivity and
specificity were 65.0%, 56.2% respectively (AUC= 0,585 95% CI (0,500-0,670), p=0.05).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; EBUS has a key role in differential diagnosis of lymphadenopathies. PET tomography
SUV-max value and tomographic lymph node density could help clinician to increase diagnostic value
of EBUS in borderline suspicious lymphadenopathies.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=282</fullTextUrl>
              <keywords><keyword>density</keyword><keyword>SUV-max</keyword><keyword>EBUS-TBNA</keyword><keyword>mediastinal lymph node</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>7</startPage>
              <endPage>13</endPage>
              <doi>10.26663/cts.2026.002</doi>
              <publisherRecordId>283</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Development of a machine learning model for predicting mortality risk in thoracic surgery patients: a synthetic data study</title>
                <authors>
                              <author>
                                <name>Okan  Karatas</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Nilay Cavusoglu Yalcin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muharrem  Ozkaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gungor Efe Ozkaya</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Türkiye</affiliationName><affiliationName affiliationId="2">Department of Computer Engineering, University of Turkish Aeronautical Association, Ankara, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Accurate prediction of postoperative mortality is crucial in thoracic surgery to guide clinical
decisions and optimize patient care. The objective of this study was to demonstrate how to develop a
reproducible machine learning–based model for predicting 30-day postoperative mortality in thoracic
surgery patients, using a realistic synthetic dataset and clinically relevant perioperative variables.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We developed a machine learning (ML) model to estimate 30-day mortality
risk in thoracic (lung) surgery patients, using realistic synthetic data of 1000 patients to illustrate the
approach. Risk factors (age, sex, comorbidities, pulmonary function, etc.) and surgery type (wedge/
segmentectomy, lobectomy, pneumonectomy) were incorporated. We tested logistic regression, random
forest, and XGBoost algorithms.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; Logistic regression yielded the best performance (AUC=0.82548) on our synthetic cohort of
1000 patients. The model also demonstrated good calibration (Brier score=0.040), indicating accurate
probability estimation. Key predictors included advanced age, high ASA class, reduced FEV1, presence
of COPD, and undergoing pneumonectomy consistent with known clinical factors. Model steps are
detailed below. An appendix provides Python code for data generation and model training.&lt;p&gt;
&lt;b&gt;Conclusion:&lt;/b&gt; This work demonstrates a reproducible pipeline for risk prediction in thoracic surgery
using a synthetic dataset, aligning with modern approaches like the STS risk calculators and advanced
ML models (e.g. Predicthor). This model is intended for methodological demonstration only and is not
clinically validated for real-world use.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=283</fullTextUrl>
              <keywords><keyword>thoracic surgery</keyword><keyword>mortality prediction</keyword><keyword>machine learning</keyword><keyword>risk stratification</keyword><keyword>logistic regression</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>14</startPage>
              <endPage>22</endPage>
              <doi>10.26663/cts.2026.003</doi>
              <publisherRecordId>284</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Evaluation of pneumonectomy outcomes in lung cancer: 18 years of surgical experience and prognostic factor analysis</title>
                <authors>
                              <author>
                                <name>Bekir  Elma</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ilkay  Dogan</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet  Ulusan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Maruf  Sanli</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ahmet Ferudun Isik</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye</affiliationName><affiliationName affiliationId="2">Department of Biostatistics, Faculty of Medicine, Gaziantep University, Gaziantep, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Despite the widespread use of methods developed to preserve lung parenchyma as
much as possible, pneumonectomy remains an essential surgical treatment option, particularly for lung
cancers located centrally and/or invading bronchovascular structures. However, pneumonectomy has
historically been associated with high morbidity and mortality. This study presents the complications,
survival outcomes, and prognostic factors of patients who underwent pneumonectomy for lung cancer,
drawing on 18 years of single-center experience.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Archived patient files from patients who underwent pneumonectomy at our
center between 2006 and 2024 were retrospectively reviewed. Postoperative complications, 30- and
90-day mortality rates, overall survival, and recurrence-free survival were analyzed. Patients who
underwent and did not undergo salvage surgery were analyzed as subgroups. Kaplan–Meier analysis
was used for survival, and multivariate Cox regression analysis was used to examine prognostic factors.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; A total of 304 patients were included in the study. Postoperative 30- and 90-day mortality
rates were consistent with the literature. Although there was no significant difference in overall
survival between right and left pneumonectomy (p=0.504), the complication rate was higher in right
pneumonectomies. Multivariate analysis revealed that age, adenocarcinoma histology, N2 positivity,
receipt of adjuvant radiotherapy, and receipt of neoadjuvant therapy were independent predictors of
poor prognosis.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Pneumonectomy remains an effective treatment option for selected patients with lung
cancer. Advanced nodal disease, tumor size, and the presence of postoperative complications negatively
impact survival. Effective use of a multidisciplinary tumor board, individualized treatment, and
dedicated perioperative management are the most important criteria for improving long-term survival.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=284</fullTextUrl>
              <keywords><keyword>pneumonectomy</keyword><keyword>lung cancer</keyword><keyword>salvage surgery</keyword><keyword>postoperative complications</keyword><keyword>bronchopleural fistula</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>23</startPage>
              <endPage>36</endPage>
              <doi>10.26663/cts.2026.004</doi>
              <publisherRecordId>285</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Global patterns of surgical research production: a bibliometric analysis of thoracic surgery literature</title>
                <authors>
                              <author>
                                <name>Omer  Yavuz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mehlika  Iscan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Eren  Erdogdu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Reyhan  Ertan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muhammet  Kertmen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Turkan  Dubus</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Yeginsu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Basaksehir Cam and Sakura City Hospital, Basaksehir, Istanbul, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Scientific studies with comparable methodological quality may not achieve similar levels
of publication visibility. This study aimed to assess whether publication visibility in the thoracic surgery
literature varies across institutional and geographic contexts, using primary spontaneous pneumothorax
(PSP) as a homogeneous clinical framework.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; This descriptive bibliometric analysis included PSP-related publications
indexed in the Web of Science Core Collection between January 1, 2000, and October 15, 2025. In
total, 972 publications were analyzed. Author name origin and gender were inferred using the NamSor
API (version 2). Author and institutional country income levels were classified according to World
Bank definitions as high-income (HIC) or low- and middle-income (LMIC). Journal impact factor and
quartile (Q1-Q4) rankings were obtained from the most recent Journal Citation Reports.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;Based on name origin, 73.9% of first authors were from high-income countries (HICs), while
26.1% were from low-and middle-income countries (LMICs). According to institutional affiliation,
83.4% of publications originated from HIC institutions and 16.6% from LMIC institutions. Overall,
95.2% of publications were published in journals based in HICs. Studies led by authors from highincome
countries were associated with publication in higher-impact and higher-quartile journals (p &lt;
0.001). Gender distribution was comparable across groups, and variations in impact factor were more
strongly associated with institutional income level than with gender.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;Despite comparable methodological characteristics, publications led by authors and
institutions from high-income countries demonstrated greater publication visibility in the PSP literature.
Greater transparency in editorial processes may help improve equity in research dissemination.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=285</fullTextUrl>
              <keywords><keyword>bibliometrics</keyword><keyword>thoracic surgery</keyword><keyword>primary spontaneous pneumothorax</keyword><keyword>institutional affiliation</keyword><keyword>publication visibility</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>37</startPage>
              <endPage>44</endPage>
              <doi>10.26663/cts.2026.005</doi>
              <publisherRecordId>286</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Prognostic factors for recurrence after surgical resection in early-stage nonsmall cell lung cancer</title>
                <authors>
                              <author>
                                <name>Gizem Özçıbık Işık</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Akif  Turna</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Burcu Sena Aydın</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Boran  Polat</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Burcu  Kılıç</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Ezel  Erşen</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Hasan Volkan Kara</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Mehmet Kamil Kaynak</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Disease and Thoracic Surgery Education and Research Hospital, Istanbul, Turkiye</affiliationName><affiliationName affiliationId="2">Department of Thoracic Surgery, Cerrahpasa Medical Faculty, Istanbul University, Cerrahpasa, Istanbul, Turkiye</affiliationName><affiliationName affiliationId="3">Department of Emergency Medicine, Karamanoğlu Mehmet Bey University, Karaman, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background:&lt;/b&gt; Non-small cell lung cancer (NSCLC) constitutes the majority of lung cancer cases, with
surgical resection being the main treatment for stages 1 and 2. Despite advances, postoperative recurrence
remains a major cause of mortality. Identifying recurrence risk factors could allow individualized
follow-up strategies.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We retrospectively analyzed 246 patients with stage 1-2 NSCLC who
underwent surgery between 2005-2022. Stage 3 disease and neoadjuvant-treated cases were excluded.
Clinical, laboratory, radiological, and surgical data were collected. Recurrences (locoregional or distant)
within at least two years of follow-up were recorded. Comparisons were made using Student’s t-test or
Chi-square test; survival was analyzed with Kaplan-Meier and Cox regression.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;VATS (Video-assisted thoracoscopic surgery) was more frequent in non-recurrence cases
(p=0.017), while pneumonectomy was more common in recurrence cases (p=0.017). Advanced T
and TNM stages, lymphatic and vascular invasion were significantly associated with recurrence. Cox
regression identified N1 disease, pleural invasion, and lymphatic invasion as independent predictors
of poor survival. Pneumonectomy and lymphatic invasion were significantly associated with reduced
recurrence-free survival.&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Recurrence after early-stage NSCLC surgery is linked to worse survival. Pneumonectomy
and lymphatic invasion may predispose to recurrence, warranting closer follow-up and consideration
of adjuvant therapy.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=286</fullTextUrl>
              <keywords><keyword>non-small cell lung cancer</keyword><keyword>early stage</keyword><keyword>recurrence</keyword><keyword>prognosis</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>45</startPage>
              <endPage>51</endPage>
              <doi>10.26663/cts.2026.006</doi>
              <publisherRecordId>287</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Changing phenotypes of pediatric empyema in the covid-19 era</title>
                <authors>
                              <author>
                                <name>Asya Eylem Boztas</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayse Demet Payza</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Arzu  Sencan</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Pediatric Surgery, Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital, University of Health Sciences, Izmir, Türkiye</affiliationName><affiliationName affiliationId="2">Department of Pediatric Surgery, Dr. Behcet Uz Pediatric Diseases and Surgery Training and Research Hospital, Izmir Faculty of Medicine, University of Health Sciences, Izmir, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;This study aimed to investigate whether the disease phenotype of pleural effusion and
empyema in children changed across the COVID-19 periods, by analyzing clinical, biochemical, and
radiological parameters among culture negative pediatric patients.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;A retrospective analysis of 147 pediatric patients treated for thoracic empyema
between 2012 and 2025 was conducted. Patients with current or previous SARS-CoV-2 infection were
excluded. Patients were stratified into four groups: pre-COVID (≤2019), pandemic (2020-2021), early
post-COVID (2022), and late post-COVID (≥2023). Worsening of the disease phenotype was assessed by
the presence of lung abscess and necrotizing pneumonia. Demographic data, pleural fluid biochemistry
(pH, glucose, lactate dehydrogenase (LDH)), and radiological findings were reviewed and compared.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The prevalence of empyema-associated lung abscesses showed a trend toward increase across
periods, being higher during the pandemic (33.3%) and late post-COVID (15%) compared with the
pre-COVID era (7.4%, p = 0.054). Necrotizing pneumonia also increased numerically, reaching 35%
in the late post-COVID period. LDH levels were significantly higher in the escalation group (4614.54
± 4504.62 U/L) compared with the non-escalation group (2493.74 ± 4415.49 U/L, p = 0.015). Oxygen
requirement (p = 0.020), ICU admission (p &lt; 0.001) and secondary intervention requirements differed
significantly across periods (p = 0.046), with the highest rates observed in the early post-COVID group.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;In SARS-CoV-2 negative pediatric patients, empyema presenting in the post-pandemic
period was associated with increased respiratory support requirements. These findings may reflect
pandemic-related alterations in disease behavior and support earlier consideration of treatment escalation.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=287</fullTextUrl>
              <keywords><keyword>empyema</keyword><keyword>COVID-19 era</keyword><keyword>pediatrics</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>52</startPage>
              <endPage>61</endPage>
              <doi>10.26663/cts.2026.007</doi>
              <publisherRecordId>288</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Inflammatory and nutritional biomarker changes at postoperative days 25-34 after uniportal minimally invasive anatomical lung resection for nonsmall cell lung cancer</title>
                <authors>
                              <author>
                                <name>Mehlika  Iscan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Omer  Yavuz</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali  Yeginsu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Blood-based inflammatory and nutritional biomarkers are increasingly used in non-small
cell lung cancer (NSCLC), but their early postoperative behavior after uniportal minimally invasive
anatomical lung resection remains unclear. This study evaluated perioperative changes in selected
indices between the preoperative period and the standardized early postoperative outpatient assessment.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; This retrospective observational study included 48 consecutive patients with
histopathologically confirmed NSCLC who underwent uniportal minimally invasive anatomical lung
resection between January 2024 and December 2025. Patients who underwent completion resection, had
non-NSCLC histology, or lacked paired laboratory data were excluded. Preoperative laboratory values
were compared with those obtained at the postoperative outpatient assessment between postoperative days
25 and 34. The primary endpoint was the change in hemoglobin, albumin, lymphocyte, and platelet score
(HALP). Secondary endpoints were changes in neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio,
prognostic nutritional index, C-reactive protein-to-albumin ratio, and systemic immune-inflammation index.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The cohort included 37 uniportal video-assisted thoracic surgery and 11 uniportal roboticassisted
thoracic surgery patients. HALP decreased significantly, whereas platelet-to-lymphocyte
ratio and C-reactive protein-to-albumin ratio increased significantly. Hemoglobin and hematocrit
decreased, while platelet count and C-reactive protein increased. No significant changes were observed
in neutrophil-to-lymphocyte ratio, prognostic nutritional index, systemic immune-inflammation index,
white blood cell count, neutrophil count, lymphocyte count, creatinine, or albumin.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;The standardized postoperative outpatient assessment after uniportal minimally invasive
anatomical lung resection for NSCLC suggested a selective biomarker pattern that may reflect a nonuniform
early postoperative recovery process after uniportal anatomical lung resection.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=288</fullTextUrl>
              <keywords><keyword>carcinoma</keyword><keyword>non-small cell lung</keyword><keyword>biomarkers</keyword><keyword>thoracic surgery</keyword><keyword>video-assisted</keyword><keyword>robotic surgical procedures</keyword><keyword>hemoglobin</keyword><keyword>albumin</keyword><keyword>lymphocyte</keyword><keyword>platelet score</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>62</startPage>
              <endPage>71</endPage>
              <doi>10.26663/cts.2026.008</doi>
              <publisherRecordId>289</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Extended lung resections for nsclc with adjacent structure involvement: a single-center experience</title>
                <authors>
                              <author>
                                <name>Okan  Karataş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Berkay  Şen</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Nilay Çavuşoğlu Yalçın</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Gürhan Sinan Özgünlü</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayşegül  Güler</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Emin  Mert</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muharrem  Özkaya</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Türkiye</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;Extended lung resections for non-small cell lung cancer (NSCLC) requiring en bloc
resection of adjacent structures remain technically demanding procedures and are associated with
considerable perioperative risk. This study analyzes the outcomes of 29 consecutive patients undergoing
extended lung resections, focusing on survival outcomes and potential prognostic factors.&lt;p&gt;
&lt;b&gt;Materials and Methods:&lt;/b&gt; We retrospectively analyzed 29 patients who underwent extended lung
resections for non-small cell lung cancer (NSCLC) with suspected or confirmed invasion of adjacent
structures between 2015 and 2023 at our institution. Extended resections included en bloc removal of
structures such as the chest wall, pericardium, diaphragm, or vascular structures when necessary to achieve
tumor clearance. Patient demographics, operative characteristics, pathological findings, postoperative
complications, and long-term survival outcomes were evaluated using Kaplan–Meier survival analysis.&lt;p&gt;
&lt;b&gt;Results: &lt;/b&gt;The cohort included 26 males (89.7%) and 3 females (10.3%) with a mean age of 64.4 ±
10.7 years. Squamous cell carcinoma was the predominant histology (65.5%). TNM staging revealed
Stage IB (34.5%) and Stage IIA (20.7%) as most frequent. All patients underwent thoracotomy with
extended resections: chest wall (58.6%), pericardium (20.7%), and combined procedures (20.7%). R0
resection was achieved in 51.7% of patients. Mean operative time was 159 ± 62 minutes. Postoperative
complications occurred in 27.6% of patients, with zero 30-day mortality. Mean follow-up was 29.4 ±
24.1 months with overall mortality of 72.4% and median survival of 24.0 months. Chest wall resection
patients had higher mortality (82.4%) compared to other extended procedures (58.3%).&lt;p&gt;
&lt;b&gt;Conclusions:&lt;/b&gt; Extended lung resections may be performed with acceptable operative mortality in carefully
selected patients. However, long-term survival remains limited, particularly in patients requiring chest wall
resection. Rigorous patient selection and multidisciplinary evaluation are crucial for optimal outcomes.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=289</fullTextUrl>
              <keywords><keyword>extended lung resection</keyword><keyword>non-small cell lung cancer</keyword><keyword>chest wall resection</keyword><keyword>survival analysis</keyword><keyword>locally advanced lung cancer</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>72</startPage>
              <endPage>81</endPage>
              <doi>10.26663/cts.2026.009</doi>
              <publisherRecordId>290</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Video-assisted thoracoscopic lung-sparing tracheobronchial and carinal resections: a single-center experience</title>
                <authors>
                              <author>
                                <name>Merve Ekinci Fidan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Volkan  Erdoğu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Melike  Ülker</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ali Cevat Kutluk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ezgi  Kılıçaslan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Meral Selin Onay Mahmuti</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Nisa  Yıldız</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Ayşegül  Çiftçi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muzaffer  Metin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkey</affiliationName></affiliationsList><abstract language="eng">&lt;b&gt;Background: &lt;/b&gt;In selected patients, lung-sparing airway resections may achieve complete oncological
resection while preserving pulmonary parenchyma. With increasing experience in video-assisted
thoracoscopic surgery (VATS), these complex procedures can now be performed using minimally
invasive techniques. We aimed to present our single-center experience with VATS lung-sparing
tracheobronchial and carinal resections, focusing on perioperative outcomes.&lt;p&gt;
&lt;b&gt;Materials and Methods: &lt;/b&gt;Data from 7 patients who underwent VATS lung-sparing airway resections
in our clinic between February 2022 and December 2024 were retrospectively evaluated in terms of
surgical indications, as well as preoperative, intraoperative, and postoperative conditions.&lt;p&gt;
&lt;b&gt;Results:&lt;/b&gt; The surgical procedures included isolated carinal resection and reconstruction in two patients,
main bronchial bronchotomy with bronchoplastic resection and reconstruction in two patients, segmental
sleeve resection of the right main bronchus in one patient, and segmental sleeve resection of the bronchus
intermedius in two patients, including one posterior biportal and one anterior uniportal approach. The
mean age was 46.4 ± 17.1 years (range: 26-67). Pathological diagnoses included four typical carcinoid
tumors, one glomus tumor, one sarcoma, and one squamous cell carcinoma. All resections achieved
negative surgical margins. Postoperatively, the mean time to chest drain removal was 1.86 ± 0.38 days,
and the mean length of hospital stay was 4.43 ± 1.40 days. No intraoperative mortality occurred, and no
major postoperative complications or anastomotic failures were observed.&lt;p&gt;
&lt;b&gt;Conclusions: &lt;/b&gt;VATS lung-sparing tracheobronchial and carinal resections are feasible and safe in
carefully selected patients. These procedures allow complete oncological resection while preserving
lung parenchyma, with favorable perioperative outcomes and short hospital stays. Minimally invasive
lung-sparing airway surgery may offers a valuable alternative to more extensive resections in selected
tracheobronchial tumors.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=290</fullTextUrl>
              <keywords><keyword>VATS</keyword><keyword>tracheobronchial resection</keyword><keyword>carinal resection</keyword><keyword>lung-sparing surgery</keyword><keyword>minimally invasive surgery</keyword><keyword>bronchoplasty</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>82</startPage>
              <endPage>88</endPage>
              <doi>10.26663/cts.2026.017</doi>
              <publisherRecordId>291</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Technological evolution of uniportal video-assisted thoracoscopic surgery in lung cancer: a comprehensive review</title>
                <authors>
                              <author>
                                <name>Hussein  Elkhayat</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Celal Bugra Sezen</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Cardiothoracic Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt</affiliationName><affiliationName affiliationId="2">University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Thoracic Surgery, Istanbul, Türkiye</affiliationName></affiliationsList><abstract language="eng">In this review, we will examine how uniportal video-assisted thoracoscopic surgery (U-VATS)
compares in the management of non-small cell lung cancer (NSCLC) in terms of effectiveness, safety,
and advancements in technology, as supported by recent literature. The change from multiportal
techniques to uniportal techniques has expanded the limits of minimal invasiveness in thoracic surgery.
In all aspects evaluated in the literature included in this review, U-VATS is comparable to multiportal
techniques in postoperative pain, drainage time, and oncologic outcomes. The learning curve criteria
set by the ESTS consensus for the safe adoption of U-VATS provides a sound basis for promoting this
technique. In essence, Uniportal VATS is an evolving technique that is equally minimally invasive and
has great oncologic potential, given advancements in technology.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=291</fullTextUrl>
              <keywords><keyword>uniportal VATS</keyword><keyword>lung cancer</keyword><keyword>minimally invasive surgery</keyword><keyword>sleeve resection</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>89</startPage>
              <endPage>91</endPage>
              <doi>10.26663/cts.2026.010</doi>
              <publisherRecordId>292</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Traumatic pneumopericardium: a rare clinical condition developing on the fifth day after trauma</title>
                <authors>
                              <author>
                                <name>Esra  Şahiner</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hüseyin  Yıldıran</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Atilla  Can</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tuba  Şahinoğlu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Selçuk University, Faculty of Medicine, Konya, Türkiye</affiliationName></affiliationsList><abstract language="eng">Pneumopericardium is a rare pathology that may occur following blunt or penetrating thoracic trauma,
iatrogenically after certain medical interventions, or due to specific infections. It is most commonly
observed after trauma and presents with a wide spectrum of clinical manifestations. The presented case
is noteworthy as it involves pneumopericardium that developed on the fifth day of follow-up for a rib
fracture sustained after a fall from height. This case highlights the diagnosis, monitoring, and treatment
approach to traumatic pneumopericardium.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=292</fullTextUrl>
              <keywords><keyword>trauma</keyword><keyword>pneumopericardium</keyword><keyword>rib fracture</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>92</startPage>
              <endPage>95</endPage>
              <doi>10.26663/cts.2026.011</doi>
              <publisherRecordId>293</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Glomus tumour of the trachea: a rare case</title>
                <authors>
                              <author>
                                <name>Ufuk Emre Keskin</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Can  Kutlay</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tevfik  Kaplan</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Eylem Pınar Eser</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Serdar  Han</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Division of Thoracic Surgery, Ankara Etlik City Hospital, Ankara, Türkiye</affiliationName><affiliationName affiliationId="2">Division of Pathology, Ankara Etlik City Hospital, Ankara, Türkiye</affiliationName></affiliationsList><abstract language="eng">This case report presents a rare case of a benign tracheal glomus tumor in a 48-year-old male who
presented with progressive cough and dyspnea. Imaging revealed a proximal tracheal mass causing
partial airway obstruction, and bronchoscopy demonstrated a highly vascularized lesion. Due to the
risk of bleeding, biopsy was not performed, and PET/CT findings supported a benign etiology. The
tumor was excised via a cervical approach, and histopathological examination confirmed a benign
glomus tumor with typical immunohistochemical features. Postoperative recovery was uneventful; no
recurrence was observed during one year of follow-up. This case highlights the diagnostic challenges
of tracheal glomus tumors, the importance of imaging and surgical flexibility in management, and the
favorable prognosis achievable with complete surgical resection and vigilant long-term follow-up.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=293</fullTextUrl>
              <keywords><keyword>glomus tumor</keyword><keyword>tracheal neoplasms</keyword><keyword>airway obstruction</keyword><keyword>bronchoscopy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>96</startPage>
              <endPage>99</endPage>
              <doi>10.26663/cts.2026.012</doi>
              <publisherRecordId>294</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Chest wall epithelioid hemangioendothelioma unmasked by a hematoma: case report</title>
                <authors>
                              <author>
                                <name>Ikram  Arramach</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hicham  Harmouchi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Marouane  lakranbi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Yassine  Ouadnouni</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Mohammed  Smahi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Thoracic Surgery Department, Hassan II University Hospital, Fès, Morocco</affiliationName><affiliationName affiliationId="2">Faculty of Medicine, Pharmacy, and Dental Medicine, Sidi Mohamed Ben Abdellah University, Fès, Morocco</affiliationName></affiliationsList><abstract language="eng">Epithelioid hemangioendothelioma (EHE) is a rare neoplasm originating from vascular endothelial cells,
which can arise in varied tissue sites. We describe a case of EHE presented with submammary mass
of the left chest wall in a 25-year-old male, and his chest CT scan revealed a hematoma. The patient
underwent a resection of the mass and the pathologic examination confirmed the diagnosis of epithelioid
hemangioendothelioma. Five months later, He developed a firm nodule at his surgical scar. He had a
second surgery consisting of excision of the local recurrence and partial resection of the sixth rib, including
the intercostal space of the chest wall. To cover the remaining defect, we used polypropylene mesh, with
muscle advancement and primary skin closure. The patient subsequently received radiotherapy and
remains under active surveillance. This case highlights the challenges of preoperative diagnosis and that
EHE should be considered in the differential diagnosis of chest wall masses.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=294</fullTextUrl>
              <keywords><keyword>epithelioid hemangioendothelioma</keyword><keyword>chest wall tumor</keyword><keyword>vascular tumor</keyword><keyword>soft tissues</keyword><keyword>surgical treatment</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>100</startPage>
              <endPage>104</endPage>
              <doi>10.26663/cts.2026.013</doi>
              <publisherRecordId>295</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Cough-induced spontaneous intercostal lung herniation: a case report</title>
                <authors>
                              <author>
                                <name>Azat  Özel</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Onur  Akçay</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Özgür  Öztürk</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Tuba  Acar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Soner  Gürsoy</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Bakircay University, Cigli Training and Research Hospital, İzmir, Türkiye</affiliationName></affiliationsList><abstract language="eng">Spontaneous lung herniation is a rare clinical entity caused by protrusion of lung tissue through a
weakened chest wall in the absence of trauma. Due to its nonspecific presentation, diagnosis may be
delayed or overlooked, particularly on initial imaging. We report the case of a 71-year-old obese male
who presented with acute-onset right-sided chest pain following a severe coughing episode. Initial
thoracic computed tomography revealed no significant pathology, and the patient was discharged with
conservative treatment. Due to progression of symptoms, repeat imaging demonstrated a prominent
lung herniation through the right 8th intercostal space, accompanied by minimal pleural effusion.
Magnetic resonance imaging revealed a 9x1 cm intercostal defect. Surgical repair was performed via
thoracotomy with reduction of the herniated lung tissue, approximation of the ribs, and reconstruction
of the defect using a nonabsorbable polypropylene mesh. The postoperative course was uneventful, and
the patient was discharged on postoperative day seven. This case highlights the diagnostic challenge of
false-negative initial computed tomography and emphasizes the importance of repeat advanced imaging
in patients with progressive symptoms. Spontaneous lung herniation should be considered in obese
male patients presenting with localized chest pain and chest wall swelling following severe coughing.
Initial imaging may fail to detect the condition, and repeat evaluation with computed tomography or
magnetic resonance imaging is crucial in cases of clinical progression. Surgical repair is a safe and
effective treatment option for symptomatic patients or those with large defects, leading to favorable
outcomes and low recurrence rates.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=295</fullTextUrl>
              <keywords><keyword>spontaneous lung herniation</keyword><keyword>intercostal</keyword><keyword>cough-induced chest wall defect</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>105</startPage>
              <endPage>108</endPage>
              <doi>10.26663/cts.2026.014</doi>
              <publisherRecordId>296</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Asymptomatic discovery of a rare congenital vascular anomaly in a 33-year-old male: a case of pulmonary sling syndrome</title>
                <authors>
                              <author>
                                <name>Bayram  Altuntaş</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Hacer  Bal</name>
                                <affiliationId>2</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Life Hospital, Antalya, Türkiye</affiliationName><affiliationName affiliationId="2">Department of Radiology, Life Hospital, Antalya, Türkiye</affiliationName></affiliationsList><abstract language="eng">Pulmonary sling (PS) syndrome is a rare congenital vascular anomaly characterized by the anomalous
origin of the left pulmonary artery (LPA) from the right pulmonary artery (RPA). While it typically
presents in infancy with severe respiratory distress, its diagnosis in adulthood is exceedingly rare and
often incidental. A 33-year-old male presented with acute, severe right-sided pleuritic chest pain.
Initial suspicion was pulmonary embolism (PE); however, laboratory markers (D-dimer, troponin) were
normal. Pulmonary CT angiography ruled out PE but revealed an incidental pulmonary sling, where the
LPA originated from the RPA and coursed between the trachea and esophagus. A 10 mm pleural effusion
was noted. The patient was diagnosed with idiopathic pleurisy, treated with anti-inflammatory agents,
and symptoms resolved. This case underscores the possibility of PS remaining asymptomatic until the
fourth decade of life. Clinicians should be aware of such vascular variants, as they may have significant
implications for airway management and thoracic surgery.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=296</fullTextUrl>
              <keywords><keyword>pulmonary artery</keyword><keyword>vascular ring</keyword><keyword>incidental findings</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>109</startPage>
              <endPage>113</endPage>
              <doi>10.26663/cts.2026.015</doi>
              <publisherRecordId>297</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Coexistence of achalasia cardia and hirschsprung’s disease in a child: a rare case report</title>
                <authors>
                              <author>
                                <name>Bolaji A. Akanni</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Akputa A. Obasi</name>
                                <affiliationId>2</affiliationId>
                              </author>
                              <author>
                                <name>Stephen A. Ezeanwu</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Chukwunyere C. Obi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Godgift N. Offor</name>
                                <affiliationId>3</affiliationId>
                              </author>
                              <author>
                                <name>Kelvin I. Nweke</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Kosisochukwu M. Igwe</name>
                                <affiliationId>3</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria</affiliationName><affiliationName affiliationId="2">Division of Paediatric Surgery, Department of Surgery, Alex Ekwueme Federal University Teaching Hospital; Ebonyi State University, Abakaliki, Ebonyi State, Nigeria</affiliationName><affiliationName affiliationId="3">Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria</affiliationName></affiliationsList><abstract language="eng">Achalasia cardia and Hirschsprung’s disease are distinct pediatric gastrointestinal motility disorders
that rarely manifest in a single patient. While both involve a failure of muscular relaxation within the
enteric nervous system, they typically present with disparate clinical features. We report an exceedingly
rare case of a 3-year-old girl who initially presented with classic signs of achalasia cardia, including
progressive dysphagia and regurgitation. Following a successful Heller’s cardiomyotomy, the patient’s
esophageal symptoms improved; however, her recovery was hampered by emerging constipation
and significant abdominal distension. Initially attributed to protein-energy malnutrition, these lower
gastrointestinal symptoms prompted further investigation, which ultimately revealed a concurrent
diagnosis of Hirschsprung’s disease. The patient subsequently underwent a posterior anal myectomy,
which led to the complete resolution of her symptoms and a full recovery. This case underscores the
diagnostic complexity of dual motility pathologies. It emphasizes that persistent or evolving symptoms
following a primary surgical intervention should prompt a high index of suspicion for additional
underlying conditions, requiring a comprehensive and multidisciplinary diagnostic approach to ensure
favorable pediatric outcomes.</abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=297</fullTextUrl>
              <keywords><keyword>achalasia cardia</keyword><keyword>Hirschsprung’s disease</keyword><keyword>pediatric GI disorders</keyword><keyword>Heller’s cardiomyotomy</keyword><keyword>anal myectomy</keyword>
                  </keywords>
            </record>


            <record>
              <language>eng</language>
              <publisher>Turkish Society of Thoracic Surgery</publisher>
              <journalTitle>Current Thoracic Surgery</journalTitle>
              <issn></issn>
              <eissn>2548-0316</eissn>
              <publicationDate>0000-00-00</publicationDate>
              <volume>11</volume>
              <issue>1</issue>
              <startPage>114</startPage>
              <endPage>115</endPage>
              <doi>10.26663/cts.2026.016</doi>
              <publisherRecordId>298</publisherRecordId>
              <documentType>article</documentType>
              <title language="eng">Calcified fibrothorax as a sequela of long-standing untreated empyema</title>
                <authors>
                              <author>
                                <name>Zeeshan  Sarwar</name>
                                <affiliationId>1</affiliationId>
                              </author>
                              <author>
                                <name>Muhammad Shoaib Nabi</name>
                                <affiliationId>1</affiliationId>
                              </author>
                      </authors>
              <affiliationsList><affiliationName affiliationId="1">Department of Thoracic Surgery, Services Institute of Medical Sciences (SIMS), Services Hospital, Lahore, Punjab, Pakistan</affiliationName></affiliationsList><abstract language="eng"></abstract>
              <fullTextUrl format="pdf">https://cts.tgcd.org.tr/pdf.php?id=298</fullTextUrl>
              <keywords><keyword>empyema thoracis</keyword><keyword>fibrothorax</keyword><keyword>thoracotomy</keyword><keyword>computed tomography</keyword>
                  </keywords>
            </record></records>